Login

Matt Brown, CFO of Livetiles Ltd (ASX: LVT), discussed with Satori Fund's Founder Dan Niles about energy prices being a significant concern. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Casius Mining's Promising Gold Exploration in Ghana: Insights from James at the One-to-One Conference
00:10:00
International Arbitration: Navigating Complex Cross-Border Disputes
00:00:00
Harry Fleming, CEO, Nobilis Health Corp
00:10:00
Setting Effective Financial Goals: From Resolutions to Results
00:10:00
CEO traces path from undergrad cancer biology interest to oncology biotech leadership | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
Initiator Pharma A/S, a biotech company based in Århus, Denmark, focuses on developing the drug candidate IPED2015.
00:10:00
David Mason of Dark Horse Resources outlines gold and lithium projects in Argentina.
00:10:00
Skills Gap: Insights from EIF Experts | Antonia Botsari - Senior Research Analyst, European Investment Fund
00:10:00
operators working to fund and assist promising Indiana-based companies at the earliest stages|Christopher (Toph) Day,Chief Executive Officer,Elevate Ventures
00:10:00
Own Real Estate Without the Hassle when real state is hassle|Ellis Hammond,CEO,Symphony Capital LLC
00:10:00
Paying Yourself First: What It Means and How to Do It | Ian draws , Founder , Open World Financial Life Planning.
00:10:00
Progress and Performance: Tom Williams on Downing Renewables & Infrastructure Trust PLC | Tom William, Manager, Downing Renewables and Infrastructure Trust PLC.

© 2017 - Neuhu+